Back to Journals » Cancer Management and Research » Volume 13
Original Research
Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,179 | Dovepress* | 3,815+ | 350 | 4,165 | |
PubMed Central* | 364 | 173 | 537 | ||
Totals | 4,179 | 523 | 4,702 | ||
*Since 14 September 2021 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar